Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive genomic profiling of combined small cell lung cancer.
Zhang J, Zhang L, Luo J, Ge T, Fan P, Sun L, Hou L, Li J, Yu H, Wu C, Zhu Y, Wu C, Jiang G, Troncone G, Malhotra J, Okuda K, Santarpia M, Zamarchi R, Goto T, Cardona AF, Xu J, Chen Q, Zhang Z, Zhang P; written on behalf of the AME Lung Cancer Collaborative Group. Zhang J, et al. Among authors: okuda k. Transl Lung Cancer Res. 2021 Feb;10(2):636-650. doi: 10.21037/tlcr-20-1099. Transl Lung Cancer Res. 2021. PMID: 33718010 Free PMC article.
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent motion-derived parameters and apparent diffusion coefficient.
Yuan Z, Niu XM, Liu XM, Fu HC, Xue TJ, Koo CW, Okuda K, Yao F, Ye XD. Yuan Z, et al. Among authors: okuda k. Transl Lung Cancer Res. 2021 Aug;10(8):3671-3681. doi: 10.21037/tlcr-21-610. Transl Lung Cancer Res. 2021. PMID: 34584865 Free PMC article.
Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer.
Uemoto Y, Katsuta E, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Terada M, Kato A, Okuda K, Sugiura H, Komura M, Kato H, Osaga S, Takahashi S, Toyama T. Uemoto Y, et al. Among authors: okuda k. Am J Cancer Res. 2022 Apr 15;12(4):1593-1605. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530276 Free PMC article.
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort.
Zou Z, Gu Y, Liang L, Hao X, Fan C, Xin T, Zhao S, Liu Z, Guo Y, Ma K, Li H, Zhang C, Shan L, Zhang Y, Dong G, Peng Y, Shen F, Song X, Christopoulos P, van der Wekken AJ, Okuda K, Ekman S, Xing P, Li J. Zou Z, et al. Among authors: okuda k. Transl Lung Cancer Res. 2022 Dec;11(12):2495-2506. doi: 10.21037/tlcr-22-803. Transl Lung Cancer Res. 2022. PMID: 36636411 Free PMC article.
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
He C, Ni M, Liu J, Teng X, Ke L, Matsuura Y, Okuda K, Sakairi Y, Cheng J, Yu L, Lv W, Hu J. He C, et al. Among authors: okuda k. Transl Lung Cancer Res. 2024 Mar 29;13(3):573-586. doi: 10.21037/tlcr-24-119. Epub 2024 Mar 27. Transl Lung Cancer Res. 2024. PMID: 38601448 Free PMC article.
2,865 results